The Armed Forces Institute of Regenerative Medicine (AFIRM) is a multi-institutional, interdisciplinary network working to develop advanced treatment options for our severely wounded servicemen and women. The AFIRM is managed and funded through the US Army Medical Research and Development Command (MRDC); with additional funding from the US Navy, Office of Naval Research; the US Air Force, Office of the Surgeon General; the National Institutes of Health; the Veterans Administration; the Department of Defense, Health Affairs and local public and private matching funding.
This website provides an introduction and status to the Armed Forces Institute of Regenerative Medicine (AFIRM) and contains official Government information. The AFIRM currently is managed by the Combat Casualty Care Research Program (CCCRP)/Joint Program Committee (JPC)-6.
Its use is intended for members of the general public, news media and Military Health System beneficiaries.
Please address questions or concerns about this website to the USAMRDC Public Affairs Office at USArmy.Detrick.USAMRDC.List.Webmaster@health.mil or by telephone at 301-619-2736.
Last Modified Date: 05 Dec 2022